These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6146391)

  • 21. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
    Williams JH; Holland M; Lee JC
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
    Fletcher JE; Rosenberg H
    Anesthesiology; 1985 Aug; 63(2):190-4. PubMed ID: 4025868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
    Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
    Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
    Fletcher JE; Rosenberg H
    Br J Anaesth; 1986 Dec; 58(12):1433-9. PubMed ID: 3790395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
    Lehmann-Horn F; Iaizzo PA
    Br J Anaesth; 1990 Nov; 65(5):692-7. PubMed ID: 2248848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro contracture tests for susceptibility to malignant hyperthermia.
    Rosenberg H; Reed S
    Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
    Olgin J; Rosenberg H; Allen G; Seestedt R; Chance B
    Anesth Analg; 1991 Jan; 72(1):36-47. PubMed ID: 1984374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
    Ording H
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant hyperthermia: slow sodium current in cultured human muscle cells.
    Wieland SJ; Fletcher JE; Rosenberg H; Gong QH
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C759-65. PubMed ID: 2552820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
    Allen GC; Larach MG; Kunselman AR
    Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calmodulin-antagonist drugs and porcine malignant hyperpyrexia.
    Collins SP; White MD; Denborough MA
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):473-7. PubMed ID: 3271620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
    Gallant EM; Godt RE; Gronert GA
    J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between the neuroleptic malignant syndrome and malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Adnet-Bonte CA; Saulnier F; Dupuis BA
    Acta Anaesthesiol Scand; 1989 Nov; 33(8):676-80. PubMed ID: 2588999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
    Britt BA; Frodis W; Scott E; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1982 Nov; 29(6):550-62. PubMed ID: 7139394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford H; Imbenotte M
    Anesthesiology; 1992 Apr; 76(4):544-9. PubMed ID: 1372490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.